Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Completes Plan B One-Step Asset Sale To Foundation Consumer Healthcare For $675M
Teva Pharmaceuticals - Wikipedia
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
Teva to pay $225 million to settle cholesterol drug price-fixing charges | The Times of Israel
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Closure of another criminal case will help Teva's new CEO to focus on return to growt | Ctech
Teva Pharmaceuticals | LinkedIn
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
PharmaBoardroom - TEVA
Teva Pharmaceutical posts rise in Q3 2023 net income to $80m
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva profit plummets, stock slides | Ctech
Israeli drug manufacturer Teva at center of anti-trust lawsuit brought by 44 states - Jewish Telegraphic Agency
Teva hi-res stock photography and images - Alamy
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Teva to Acquire Mexico's Rimsa for $2.3 Billion - WSJ
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
What does Teva's growth strategy look like?
